Artal Group S.A. Applied Therapeutics Inc. Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.25 - $7.4 $2.27 Million - $7.47 Million	1,009,500 New	1,009,500 $6.86 Million
Q1 2021 May 14, 2021	BUY	$16.57 - $28.65 $331,400 - $573,000	20,000 Added 5.26%	400,000 $7.5 Million
Q3 2020 Nov 13, 2020	BUY	$19.43 - $35.36 $7.38 Million - $13.4 Million	380,000 New	380,000 $7.89 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $462M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.